An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-FU (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer
Nom du journal : Breast Cancer Res Treat
Année : 2001
Volume : 70
Page de départ : 55
Page de fin : 63